Sniffing out the next ASX biotech takeover target
With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be next.
With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be next.
Diamond drilling at Koonenberry Gold’s newly acquired Enmore project has uncovered visible gold in the second drillhole.
Antares Metals CEO Johan Lambrechts joins Barry FitzGerald on the Explorers Podcast to chat about new opportunity in Queensland.
EZZ has served up a strong H2 FY25 result, with several financial and operational achievements throughout the quarter.
Brazilian Critical Minerals says it will occupy the very bottom end of the rare earths cost curve after a landmark scoping study for the Ema project in Brazil.
Fraser Palamara chats with Imagion Biosystems’ Robert Proulx to talk the advancements of its cancer-detecting imaging agent technology.
CSE-listed battery metals explorer American Salars Lithium has spread its wings with the acquisition of the LCT pegmatite rich Jaguaribe project in northern Brazil.
Octava Minerals has confirmed historic lithium and rare earth grades and its Byro project’s potential to host a unique Australian operation.
Decidr’s partnership with CareerOne is accelerating with the launch of an AI-driven platform that, based on early results, could enhance recruitment.
AI is changing the game, with Microsoft Muse leading the charge while Fatfish, iCandy, Aristocrat, and PlaySide Studios all level up.
Stockhead’s Fraser Palamara chats with Top End Energy’s Luke Velterop about the company’s strategic growth in Kansas and its role in the hydrogen land rush.
The 27% increase in indicated DSO resources at Akora Resources’ Bekisopa iron ore project will strengthen the upcoming pre-feasibility study.
Original URL: https://www.couriermail.com.au/business/stockhead